The Clinical Application of Ozonetherapy
Author:
- 24 September 2010
- book chapter
- Published by Springer Nature
- p. 97-232
Abstract
The reader may be eager to examine in which diseases ozonetherapy can be proficiently used and she/he will be amazed by the versatility of this complementary approach (Table 9 1). The fact that the medical applications are numerous exposes the ozonetherapist to medical derision because superficial observers or sarcastic sceptics consider ozonetherapy as the modern panacea. This seems so because ozone, like oxygen, is a molecule able to act simultaneously on several blood components with different functions but, as we shall discuss, ozonetherapy is not a panacea. The ozone messengers ROS and LOPs can act either locally or systemically in practically all cells of an organism. In contrast to the dogma that “ozone is always toxic”, three decades of clinical experience, although mostly acquired in private clinics in millions of patients, have shown that ozone can act as a disinfectant, an oxygen donor, an immunomodulator, a paradoxical inducer of antioxidant enzymes, a metabolic enhancer, an inducer of endothelial nitric oxide synthase and possibly an activator of stem cells with consequent neovascularization and tissue reconstruction.Keywords
This publication has 728 references indexed in Scilit:
- Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trialThe Lancet, 2009
- Losing and finding a way at C: New promise for pharmacologic ascorbate in cancer treatmentFree Radical Biology and Medicine, 2009
- Human longevity and 11p15.5: a study in 1321 centenariansEuropean Journal of Human Genetics, 2009
- Structural basis for androgen specificity and oestrogen synthesis in human aromataseNature, 2009
- Age-related macular degenerationThe Lancet, 2008
- The chemistry of cell signaling by reactive oxygen and nitrogen species and 4-hydroxynonenalArchives of Biochemistry and Biophysics, 2008
- Redox-dependent impairment of vascular function in sickle cell diseaseFree Radical Biology and Medicine, 2007
- Recent advances in TGF-β effects on chondrocyte metabolismCytokine & Growth Factor Reviews, 2002
- Carbonyl modified proteins in cellular regulation, aging, and disease2,3 2Guest Editor: Earl Stadtman 3This article is part of a series of reviews on “Oxidatively Modified Proteins in Aging and Disease.” The full list of papers may be found on the homepage of the journal.Free Radical Biology and Medicine, 2002
- Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinaseNature, 2002